PFKP and cancer: Moreover, the relationship between PFKP and programmed death-ligand 1 (PD-L1) in tumors, which is frequently observed in human cancer and has been developed as a biomarker for immune checkpoint inhibitor response64,65, is presented in Fig. 5A. Recent data also revealed a positive correlation between PFKP and PD-L1.